Sharon Mannheimer, MD, is an Associate Professor of Clinical Medicine at Columbia College of Physicians and Surgeons and a senior lecturer in the Department of Epidemiology at the Mailman School of Public Health. She is stationed at Harlem Hospital, where she is the head of the Infectious Diseases Department. Dr. Mannheimer's infectious disease career has focused on HIV, including clinical care for HIV-infected patients, research on adherence to HIV therapy, and research on HIV prevention. Dr. Mannheimer helps monitor HIV services at Harlem Hospital, including several Ryan White-funded programs that provide primary care and other supportive HIV services to residents of Harlem and neighboring communities. She also oversees the Harlem Hospital's rapid HIV testing program. In addition, Dr. Mannheimer, as deputy dean of the Columbia University Medical Center Affiliation at Harlem Hospital, all activities of Columbia medical students at Harlem Hospital. She serves on two faculty boards at Columbia College of Physicians and Surgeons. Dr. Mannheimer is also directly involved in teaching Infectious Disease Fellows, medical students, and medical students. She is currently involved in conducting HIV prevention research as the site director of the NIH-funded Harlem Prevention Center Clinical Research Site in Harlem and part of the ICAP of the Mailman School of Public Health in Columbia. She is the Site Principal Investigator of the ADAPT Study, a study by the HIV Prevention Trials Network that evaluates dosing strategies for pre-exposure prophylaxis (PrEP) drugs to prevent HIV infection in HIV-negative people at risk in New York City. She also serves as the New York representative for the Provider Advisory Board of the CDC's Medical Monitoring Project, which evaluates HIV treatment in the United States. She was also previously a member of the Priority Setting and Resource Allocation Committee of the HIV Health and Human Services Planning Council of New York City and was previously elected to serve as a member of the New York State Medical Care Criteria Committee that develops HIV guidelines in New York State for clinical practice HIV-infected adults. Dr. Mannheimer's interest in public health stems from her desire to reduce health inequalities among African Americans associated with HIV.
Director, Infectious Disease Department, Assistant Dean of Harlem Hospital Center, Student Affairs; Columbia University Member of Harlem Hospital New York City Representative, Provider Advisory Board, Medical Monitoring Project, Centers for Disease Control Member, American College of Physicians Member, Infectious Disease Society of America Member, International AIDS Society
areas of expertiseHIV / AIDS
Choose Urban Health Activities
HPTN 067, The ADAPT Study : An NIH-funded HIV Prevention Trials Network (HPTN) Phase II, randomized, open-label, pharmacokinetic and behavioral study of intermittent oral emtricitabine / tenofovir disoproxil fumarate (truvada) pre-exposure prophylaxis (PrEP) for the prevention of HIV infection The STAR study : Find, test and hold. Linkages for Black HIV +, Substance Using Men Who Have Sex with Men (STAR) is a NIH / NIDA-funded RO1 study evaluating an innovative method of Respondent Driven Sampling (RDS) for finding and recruiting substances with black MSM and HIV Tests for those who agree to enroll. For those diagnosed with HIV infection, the study evaluates novel interventions to link and retain them in HIV treatment.
Hodder, SL, Justman, J., Hughes, J., Wang, J., Haley, DF, Adimora, AA, Del Rio, C., Golin, C.Ee, Kuo, I., Rompalo, A., Soto -Torres, L., Mannheimer, SB, Johnson-Lewis, L., Eshleman, SH, and El-Sadr, WM, for the HIV Prevention Trials Network 06 HIV Disease in Women from Selected Areas of the United States. A cohort study. Ann Intern Med 158 10-18 2013 O'Connor, J.L., Gardner, E.M., Mannheimer, S.B., Lifson, A.R., Esser, S.E., Telzak, E. and Phillips, A.N. for the INSIGHT SMART Study Group. Factors related to the adherence of 5,295 people to antiretroviral therapy in an international study. J Infect Dis Epub 2012/12/04. doi: 10.1093 / infdis / jis731. PubMed PMID: 23204161 2012 Gardner, EM, Hullsiek, KH, Telzak, EE, Sharma, S., Peng, G., Burman, WJ, MacArthur, RD, Chesney, M., Friedland, G. and Mannheimer, SB, for the Terry Beirn Community Programs for Clinical Research on AIDS and the International Network for Stra Antiretroviral Drug Adherence and Class Resistance in a Large Prospective Clinical Trial. AIDS 24 395-403 2010 Giordano, TP, Bartsch, G., Zhang, Y., Tedaldi, E., Absalon, J., Mannheimer, S., Thomas, A. and MacArthur, RD Different results in African American and Latino Patients in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) study. AIDS patient care STDs 24 287-295 2010 Mannheimer, S., Wold, N., Gardner, EM, Telzak, EE, Huppler Hullsiek, K., Chesney, M., Wu, AW, MacArthur, RD, Matts, J. , and Friedland, G. for the Terry Beirn Community Program for Clinical Research on AIDS (CPCRA). Mild to moderate symptoms during the first year of antiretroviral therapy worsen the quality of life of HIV-infected people. Clin Infect Dis 46 941-945 2008 Gardner, EM, Sharma, S., Peng, G., Huppler Hullsiek, K., Burman, WJ, MacArthur, RD, Chesney, M., Telzak, EE, Friedland, G., Mannheimer, SB, for the Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). Differing adherence to combination antiretroviral therapy is associated with virological failure with resistance. AIDS 22 75-82 2008 Mannheimer, S., Thackeray, L., Huppler Hullsiek, K., Chesney, M., Gardner, EM, Wu, AW, Telzak, EE, Lawrence, J., Baxter, J. and Friedland , G. for the Terry Beirn Community Program for Clinical Research on AIDS (CPCRA). A randomized comparison of two instruments used to measure self-reported antiretroviral adherence. AIDS Care 20 161-169 2008 Mannheimer, S.B., Morse, E., Matts, J.P., Andrews, L., Child, C., Butter, B. and Friedland, G.H. for the Terry Beirn Community Program for Clinical Research on AIDS. Sustainable benefit from long-term antiretroviral adherence intervention: results of a large randomized clinical trial. J Acquir Immune Defic Syndr 43 (Suppl 1) S41-S47 2006 Mannheimer, S., Friedland, G., Matts, J., Child, C. and Chesney, M., for the Terry Beirn Community Programs for Clinical Research on AIDS . The consistency of adherence to antiretroviral therapy in clinical studies predicts the biological results for individuals infected with the human immunodeficiency virus. Clin Infect Dis 34 1115-1121 2002 Telzak, EE, Sepkowitz, K., Alpert, P., Mannheimer, S., El-Sadr, W., Blum, S., Gagliardi, A., Turett, G. Mulitdrug- resistant tuberculosis in patients without HIV infection. N Engl J Med 333 907-911 1995Back to top